........................................................................................................................................................ 2 1 Chapter One: Introduction .......................................................................................................................... 6 1.1 Research background .......................................................................................................................... 6 1.2 Research questions .............................................................................................................................. 8 1.3 Justifications for the research .............................................................................................................. 8 1.4 Methodology ....................................................................................................................................... 9 1.5 Structure of thesis .............................................................................................................................. 10 2 Chapter Two: Compulsory License Overview: Focus on “Failure to Work” .......................................... 11 2.1 The Operation of the Compulsory License Regime .......................................................................... 11 2.1.1 Recognized grounds ....................................................................................................................... 12 2.2.1 Scope and duration ......................................................................................................................... 14 2.1.4 Remuneration ................................................................................................................................. 19 2.2 Compulsory License among other patent limitations ........................................................................ 20 3 Chapter Three: The Interface between Human Rights and Patent Law: The Correlation between Access to Medicines and “Failure to Work” ........................................................................................................... 23 3.1 The convergence of Access to Medicines and “Failure to Work” .................................................... 23 3.1.1 Subjugation .................................................................................................................................... 23 3.1.2 Integration ...................................................................................................................................... 24 3.1.3 Coexistence .................................................................................................................................... 26 3.2 The Content of Access to Medicines ................................................................................................. 28 3.2.1 Availability and Affordability ........................................................................................................ 30 4 Chapter four: The analyze of the Bayer Nexavar case ............................................................................ 32 4.1 Bayer in India .................................................................................................................................... 32 4.2. Before the Controller of Patents in Mumbai .................................................................................... 32 4.3 Before the Before the Intellectual Property Appellate Board ........................................................... 36 4.4 On the Ability of “Failure to Work” to Promotion Access to Medicines ......................................... 41 5 Chapter five: Conclusion .......................................................................................................................... 44 5.1 Conclusion and recommendations .................................................................................................... 44 6 Chapter six: Bibliography ........................................................................................................................ 45 6.1 Reference Table ................................................................................................................................ 45